Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Lotem

Showing results (21-30 of 93) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|January 23, 2025
Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapyShay Tzaban, Ori Stern, Elad Zisman, et al.
Journal of the American Academy of Dermatology|July 10, 2004
An open trial of climatotherapy at the Dead Sea for patch-stage mycosis fungoidesEmmilia Hodak, Alice B Gottlieb, Tzvi Segal, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2016
Spontaneous Activation of Antigen-presenting Cells by Genes Encoding Truncated Homo-Oligomerizing Derivatives of CD40Noam Levin, Aviad Pato, Gal Cafri, et al.
Cellular Immunology|October 16, 2010
Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune responseGalit Eisenberg, Arthur Machlenkin, Shoshana Frankenburg, et al.
Immunology Letters|July 28, 2004
Recombinant hydrophilic human gp100: uptake by dendritic cells and stimulation of autologous CD8+ lymphocytes from melanoma patientsShoshana Frankenburg, Orit Elias, Yamit Gelbart, et al.
Journal of Translational Medicine|October 9, 2019
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithmNeta Tsur, Yuri Kogan, Evgenia Avizov-Khodak, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 26, 2006
Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectorsMichal Lotem, Yangbing Zhao, John Riley, et al.
Plos One|April 14, 2020
Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patientsNir Hirshoren, Roni Yoeli, Jonathan E Cohen, et al.
Cellular Immunology|February 16, 2008
A melanoma multiepitope polypeptide induces specific CD8+ T-cell responseAdva Levy, Jacob Pitcovski, Shoshana Frankenburg, et al.
NAR Genomics and Bioinformatics|April 11, 2022
Machine-learning of complex evolutionary signals improves classification of SNVsSapir Labes, Doron Stupp, Naama Wagner, et al.
Pageof 10

Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|January 23, 2025
Alternative splicing of modulatory immune receptors in T lymphocytes: a newly identified and targetable mechanism for anticancer immunotherapyShay Tzaban, Ori Stern, Elad Zisman, et al.
Journal of the American Academy of Dermatology|July 10, 2004
An open trial of climatotherapy at the Dead Sea for patch-stage mycosis fungoidesEmmilia Hodak, Alice B Gottlieb, Tzvi Segal, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 23, 2016
Spontaneous Activation of Antigen-presenting Cells by Genes Encoding Truncated Homo-Oligomerizing Derivatives of CD40Noam Levin, Aviad Pato, Gal Cafri, et al.
Cellular Immunology|October 16, 2010
Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune responseGalit Eisenberg, Arthur Machlenkin, Shoshana Frankenburg, et al.
Immunology Letters|July 28, 2004
Recombinant hydrophilic human gp100: uptake by dendritic cells and stimulation of autologous CD8+ lymphocytes from melanoma patientsShoshana Frankenburg, Orit Elias, Yamit Gelbart, et al.
Journal of Translational Medicine|October 9, 2019
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithmNeta Tsur, Yuri Kogan, Evgenia Avizov-Khodak, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 26, 2006
Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectorsMichal Lotem, Yangbing Zhao, John Riley, et al.
Plos One|April 14, 2020
Checkpoint inhibitors: Better outcomes among advanced cutaneous head and neck melanoma patientsNir Hirshoren, Roni Yoeli, Jonathan E Cohen, et al.
Cellular Immunology|February 16, 2008
A melanoma multiepitope polypeptide induces specific CD8+ T-cell responseAdva Levy, Jacob Pitcovski, Shoshana Frankenburg, et al.
NAR Genomics and Bioinformatics|April 11, 2022
Machine-learning of complex evolutionary signals improves classification of SNVsSapir Labes, Doron Stupp, Naama Wagner, et al.
Pageof 10